The Surgeon Minute

Wrinkle Filler Belotero Offers Quick Fix to Erase Signs of Aging

Wrinkle Filler Belotero Offers Quick Fix to Erase Signs of Aging

Wrinkle fillers come in many forms, and now a new contender is poised to hit the market. Belotero offers a fresh solution for those who want to erase signs of aging without going under the knife. Get the details — and see before and after photos — in this video interview with facial filler expert Dr. Bhushan Hardas.

eye wrinkles minimized with dermal fillersAny product that removes facial wrinkles and folds is guaranteed to draw interest from the aging masses. And once the Food and Drug Administration approves a new injectable gel called Belotero®, cosmetic customers will have another effective option to consider.

Belotero is already on the market in Germany, Canada and the United Kingdom, with American FDA approval currently pending. In an interview at the 2009 annual meeting of the American Society of Plastic Surgeons, Dr. Bhushan Hardas of Merz Pharmaceuticals explained how the product — a cohesive polydensified matrix (CPM) gel — actually works.

Article continues below video player.

Get the Flash Player to see the wordTube Media Player.

“It’s a gel, with variable density within the gel, that just makes it easier for the doctor and the patient,” Dr. Hardas said.

A key factor to Belotero is that it contains hyaluronic acid, Dr. Hardas added. The human body actually already contains this acid – which is a natural sugar – but can lose it to varying degrees through aging and lifestyle. Losing this substance in the face results in the formation of lines and wrinkles. But, when a plastic surgeon injects Belotero into a patient’s face, the new acid attracts moisture to that area – a process that creates a filler there and diminishes signs of aging.

According to the latest information, Belotero is expected to be reasonably priced and offer a quickly fix to fight facial aging, with treatments taking only up to 30 minutes. Similar to other filler products, the results last up to 12 months. Merz Pharmaceuticals submitted its approval application to the FDA in September 2009, and may soon be able to unveil it on our national market.

View Comments (1)

More in The Surgeon Minute